Free Trial

Jump Financial LLC Buys New Holdings in Teladoc Health, Inc. $TDOC

Teladoc Health logo with Medical background

Key Points

  • Jump Financial LLC has invested approximately $3.91 million in Teladoc Health, acquiring 491,225 shares during the first quarter.
  • Analysts have lowered their price targets for Teladoc Health, with a consensus rating of "Hold" and an average price target of $9.80.
  • Insiders have reportedly sold a total of 18,656 shares of Teladoc Health stock in the last 90 days, indicating some decrease in their positions.
  • Need better tools to track Teladoc Health? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Jump Financial LLC bought a new position in Teladoc Health, Inc. (NYSE:TDOC - Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 491,225 shares of the health services provider's stock, valued at approximately $3,910,000. Jump Financial LLC owned approximately 0.28% of Teladoc Health at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Cambridge Investment Research Advisors Inc. lifted its position in shares of Teladoc Health by 60.8% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 39,738 shares of the health services provider's stock worth $316,000 after buying an additional 15,030 shares in the last quarter. Golden State Wealth Management LLC lifted its holdings in shares of Teladoc Health by 102.6% in the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock valued at $27,000 after acquiring an additional 1,690 shares during the last quarter. Wedmont Private Capital lifted its stake in Teladoc Health by 20.3% in the first quarter. Wedmont Private Capital now owns 16,086 shares of the health services provider's stock worth $117,000 after purchasing an additional 2,715 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its stake in Teladoc Health by 22.1% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 14,725 shares of the health services provider's stock worth $134,000 after purchasing an additional 2,662 shares during the last quarter. Finally, Vontobel Holding Ltd. lifted its stake in Teladoc Health by 61.4% in the first quarter. Vontobel Holding Ltd. now owns 21,422 shares of the health services provider's stock worth $171,000 after purchasing an additional 8,152 shares during the last quarter. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the company. Mizuho assumed coverage on Teladoc Health in a research note on Friday, July 25th. They issued a "neutral" rating and a $10.00 price objective on the stock. The Goldman Sachs Group dropped their price objective on Teladoc Health from $13.00 to $10.00 and set a "buy" rating on the stock in a research note on Thursday, May 1st. Canaccord Genuity Group dropped their price objective on Teladoc Health from $14.00 to $12.00 and set a "buy" rating on the stock in a research note on Thursday, May 1st. Stifel Nicolaus dropped their price objective on Teladoc Health from $9.00 to $8.00 and set a "hold" rating on the stock in a research note on Thursday, May 1st. Finally, Bank of America cut their price objective on shares of Teladoc Health from $8.00 to $7.00 and set a "neutral" rating on the stock in a report on Wednesday, May 28th. Six research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $9.80.

Check Out Our Latest Analysis on TDOC

Insider Transactions at Teladoc Health

In related news, insider Fernando M. Rodrigues sold 4,174 shares of the company's stock in a transaction on Tuesday, June 3rd. The stock was sold at an average price of $6.91, for a total value of $28,842.34. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Carlos Nueno sold 3,958 shares of the company's stock in a transaction on Monday, June 2nd. The shares were sold at an average price of $6.86, for a total value of $27,151.88. Following the completion of the transaction, the insider directly owned 17,645 shares in the company, valued at approximately $121,044.70. The trade was a 18.32% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 18,656 shares of company stock valued at $128,189. Corporate insiders own 0.58% of the company's stock.

Teladoc Health Stock Down 1.9%

Shares of TDOC stock traded down $0.15 during trading hours on Friday, reaching $7.74. 3,533,595 shares of the company's stock were exchanged, compared to its average volume of 6,886,721. The stock's 50 day moving average is $7.79 and its 200-day moving average is $8.10. The company has a market cap of $1.37 billion, a price-to-earnings ratio of -6.50 and a beta of 1.76. The company has a current ratio of 2.67, a quick ratio of 2.58 and a debt-to-equity ratio of 0.70. Teladoc Health, Inc. has a fifty-two week low of $6.35 and a fifty-two week high of $15.21.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.27) by $0.08. The business had revenue of $631.90 million for the quarter, compared to the consensus estimate of $621.91 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The business's quarterly revenue was down 1.6% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.38) earnings per share. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. Analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Teladoc Health Company Profile

(Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Read More

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Should You Invest $1,000 in Teladoc Health Right Now?

Before you consider Teladoc Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.

While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

$15 Billion for Cybersecurity: The Government’s Next Big Push
Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines